| Literature DB >> 19090814 |
F J Van de Werf1, E J Topol, B E Sobel.
Abstract
As privileged witnesses of the initiation and widespread use of reperfusion therapy the authors review the history of fibrinolytic therapy and of tissue-plasminogen activator (t-PA) more particularly and the current indications for its use in the era of mechanical reperfusion.Entities:
Mesh：
Substances：
Year: 2009 PMID： 19090814 DOI： 10.1111/j.1538-7836.2008.03195.x
Source DB: PubMed Journal: J Thromb Haemost ISSN： 1538-7836 Impact factor: 5.824